ADARx Pharmaceuticals, Inc. - 8-K Filing
ADARx Pharmaceuticals closed $535.6M IPO and private placement with AbbVie on September 28, 2026 (Items: 3.02 Unregistered Sales of Equity Securities, 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 8.01 Other Events, 9.01 Financial Statements and Exhibits)